Trials / Completed
CompletedNCT00464607
Prospective, Randomized, Controlled, Clinical Study on Tolerability and Efficacy of hMG-IBSA
A Prospective, Randomized, Controlled Clinical Study on the Assessment of Tolerability and of Clinical Efficacy of MERIONAL® (hMG-IBSA) Administered Subcutaneously Versus MERIONALâ Administered Intramuscularly in Women Undergoing Controlled Ovarian Hyperstimulation (COH) in an ART Programme (IVF)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- IBSA Institut Biochimique SA · Industry
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Purpose of the study is the evaluation of the tolerability (both local and systemic) and the clinical efficacy (in terms oocytes recovered) of subcutaneously versus intramuscularly administered Merional® (IBSA, Lugano - CH) in patients undergoing controlled ovarian hyperstimulation (COH) in an ART programme (IVF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hMG-IBSA | |
| PROCEDURE | Ovarian stimulation |
Timeline
- Start date
- 2001-12-01
- Completion
- 2005-04-01
- First posted
- 2007-04-23
- Last updated
- 2007-04-23
Locations
4 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00464607. Inclusion in this directory is not an endorsement.